tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

KPTI Stock Latest News

Karyopharm Therapeutics Enhances Financial Stability and Liquidity
Company AnnouncementsKaryopharm Therapeutics Enhances Financial Stability and Liquidity
12d ago
8K
KPTI
Karyopharm still sees 2024 revenue $140M-$160M, consensus $146.52M
PremiumThe Fly
Karyopharm still sees 2024 revenue $140M-$160M, consensus $146.52M
12d ago
KPTI
Karyopharm reports Q1 EPS (32c), consensus (33c)
PremiumThe Fly
Karyopharm reports Q1 EPS (32c), consensus (33c)
12d ago
KPTI
Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
PremiumPress Releases
Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
12d ago
KPTI
Is KPTI a Buy, Before Earnings?
PremiumPre-Earnings
Is KPTI a Buy, Before Earnings?
14d ago
KPTI
Karyopharm price target lowered to $8 from $10 at H.C. Wainwright
PremiumThe FlyKaryopharm price target lowered to $8 from $10 at H.C. Wainwright
3M ago
KPTI
Bad News for Karyopharm Therapeutics INC Stock: This New Risk Has Been Added
PremiumCompany Announcements
Bad News for Karyopharm Therapeutics INC Stock: This New Risk Has Been Added
3M ago
KPTI
Karyopharm sees 2024 revenue $140M-$160M, consensus $152.02M
PremiumThe Fly
Karyopharm sees 2024 revenue $140M-$160M, consensus $152.02M
3M ago
KPTI
Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
PremiumPress Releases
Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
3M ago
KPTI
Karyopharm reports Q4 EPS (36c), consensus (31c)
PremiumThe Fly
Karyopharm reports Q4 EPS (36c), consensus (31c)
3M ago
KPTI
Karyopharm Regains Compliance, Secures Nasdaq Listing
PremiumCompany Announcements
Karyopharm Regains Compliance, Secures Nasdaq Listing
3M ago
8K
KPTI
KPTI Earnings this Week: How Will it Perform?
PremiumPre-Earnings
KPTI Earnings this Week: How Will it Perform?
3M ago
KPTI
Karyopharm CFO Michael Mason sell 4,205 shares
PremiumThe FlyKaryopharm CFO Michael Mason sell 4,205 shares
3M ago
KPTI
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
EQ
MOR
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
MOR
NVS
Morphosys interest highlights Karyopharm’s opportunity in MF, say RBC Capital
PremiumThe Fly
Morphosys interest highlights Karyopharm’s opportunity in MF, say RBC Capital
4M ago
KPTI
Karyopharm Announces Preliminary Unaudited 2023 Revenue and 2024 Objectives
PremiumPress Releases
Karyopharm Announces Preliminary Unaudited 2023 Revenue and 2024 Objectives
4M ago
KPTI
Karyopharm sees FY23 revenue $145.9M, consensus $150.03M
PremiumThe Fly
Karyopharm sees FY23 revenue $145.9M, consensus $150.03M
4M ago
KPTI
Karyopharm sees Q4 revenue $33.6M, consensus $37.64M
PremiumThe Fly
Karyopharm sees Q4 revenue $33.6M, consensus $37.64M
4M ago
KPTI
Karyopharm’s selinexor shows efficacy and safety in endometrial cancer study
PremiumThe FlyKaryopharm’s selinexor shows efficacy and safety in endometrial cancer study
7M ago
KPTI
Karyopharm price target lowered to $8 from $10 at Baird
PremiumThe Fly
Karyopharm price target lowered to $8 from $10 at Baird
7M ago
KPTI
Karyopharm price target lowered to $5 from $8 at Barclays
PremiumThe Fly
Karyopharm price target lowered to $5 from $8 at Barclays
7M ago
KPTI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >